The TREM receptor family and signal integration

TREM proteins are a family of cell surface receptors that participate in diverse cell processes, including inflammation, bone homeostasis, neurological development and coagulation. TREM-1, the first to be identified, acts to amplify inflammation. Other TREM proteins regulate the differentiation and function of macrophages, microglia, dendritic cells, osteoclasts and platelets. Here we discuss the state of the field, putative ligands of TREM proteins and the challenges that remain in understanding TREM biology.

[1]  P. Bollaert,et al.  Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis , 2004, Annals of Internal Medicine.

[2]  T. Matsuno,et al.  Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. , 2003, The American journal of pathology.

[3]  J. Jukes,et al.  Novel immunoglobulin-like transcripts in teleost fish encode polymorphic receptors with cytoplasmic ITAM or ITIM and a new structural Ig domain similar to the natural cytotoxicity receptor NKp44 , 2005, Immunogenetics.

[4]  Leena Peltonen,et al.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.

[5]  A. Mahdy,et al.  Production of Soluble Triggering Receptor Expressed on Myeloid Cells by Lipopolysaccharide-Stimulated Human Neutrophils Involves De Novo Protein Synthesis , 2006, Clinical and Vaccine Immunology.

[6]  D. McVicar,et al.  Initial characterization of TREM-like transcript (TLT)-1: a putative inhibitory receptor within the TREM cluster. , 2002, Blood.

[7]  K. Tracey,et al.  HMG‐1 REDISCOVERED AS A CYTOKINE , 2001, Shock.

[8]  L. Lanier,et al.  The Signaling Adapter Protein DAP12 Regulates Multinucleation During Osteoclast Development , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  G. Ruthel,et al.  Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses , 2006, Journal of Virology.

[10]  K. Alitalo,et al.  Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  E. Giamarellos‐Bourboulis,et al.  Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease , 2006, European journal of gastroenterology & hepatology.

[12]  L. Lanier,et al.  Cloning and characterization of a novel mouse myeloid DAP12‐associated receptor family , 2001, European journal of immunology.

[13]  W. Seaman,et al.  Characterization of TREM‐3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17 , 2002, European journal of immunology.

[14]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[15]  C. Nathan,et al.  TREM-1: A new regulator of innate immunity in sepsis syndrome , 2001, Nature Medicine.

[16]  Kenneth G. C. Smith,et al.  Cutting Edge: TREM-Like Transcript-1, a Platelet Immunoreceptor Tyrosine-Based Inhibition Motif Encoding Costimulatory Immunoreceptor that Enhances, Rather than Inhibits, Calcium Signaling via SHP-2 1 , 2004, The Journal of Immunology.

[17]  Edward H. Cho,et al.  A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets. , 2004, Blood.

[18]  M. Colonna,et al.  A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001, The Journal of experimental medicine.

[19]  J. Cobb,et al.  DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis , 2005, The Journal of experimental medicine.

[20]  J. Bell,et al.  Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor , 1992, European journal of immunology.

[21]  R. Bellomo,et al.  Sepsis--theory and therapies. , 2003, The New England journal of medicine.

[22]  Lewis L Lanier,et al.  Natural killer cell receptor signaling. , 2003, Current opinion in immunology.

[23]  C. Buonsanti,et al.  A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response1 , 2003, The Journal of Immunology.

[24]  W. Zou,et al.  High dose M‐CSF partially rescues the Dap12−/− osteoclast phenotype , 2003, Journal of cellular biochemistry.

[25]  I. Kitajima,et al.  Nasu-Hakola disease (membranous lipodystrophy) Clinical, histopathological and biochemical studies of three cases , 1989, Journal of the Neurological Sciences.

[26]  L. Lanier,et al.  TREM2, a DAP12‐Associated Receptor, Regulates Osteoclast Differentiation and Function , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  K. Tan-Takeuchi,et al.  Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. , 2003, The Journal of clinical investigation.

[28]  P. Agarwal,et al.  Sepsis--theory and therapies. , 2003, The New England journal of medicine.

[29]  L. Peltonen,et al.  DAP12/TREM2 Deficiency Results in Impaired Osteoclast Differentiation and Osteoporotic Features , 2003, The Journal of experimental medicine.

[30]  Y. Kadono,et al.  Osteoimmunology: interplay between the immune system and bone metabolism. , 2006, Annual review of immunology.

[31]  W. Seaman,et al.  Pattern Recognition by TREM-2: Binding of Anionic Ligands1 , 2003, The Journal of Immunology.

[32]  M. Colonna,et al.  Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine1 , 2005, The Journal of Immunology.

[33]  M. Béné,et al.  A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis , 2004, The Journal of experimental medicine.

[34]  D. Burshtyn,et al.  Intracellular Signaling by the Killer Immunoglobulin-Like Receptors and Ly49 , 2001, Science's STKE.

[35]  M. Netea,et al.  Triggering receptor expressed on myeloid cells‐1 (TREM‐1) amplifies the signals induced by the NACHT‐LRR (NLR) pattern recognition receptors , 2006, Journal of leukocyte biology.

[36]  G. Clark,et al.  The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17. , 2000, Tissue antigens.

[37]  C. Dinarello,et al.  Proinflammatory cytokines. , 2000, Chest.

[38]  W. Seaman,et al.  CMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast Formation1 , 2003, The Journal of Immunology.

[39]  M. Colonna,et al.  Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.

[40]  S. Beck,et al.  The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44 , 2003, European journal of immunology.

[41]  A. Satoskar,et al.  Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.

[42]  J. Trowsdale,et al.  You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling , 2006, European journal of immunology.

[43]  K. Wüthrich,et al.  Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 A. , 2004, Journal of molecular biology.

[44]  Jonathan Cohen.  The immunopathogenesis of sepsis , 2002, Nature.

[45]  H. Neumann,et al.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.

[46]  Brantley R. Herrin,et al.  Trem-Like Transcript 2 Is Expressed on Cells of the Myeloid/Granuloid and B Lymphoid Lineage and Is Up-Regulated in Response to Inflammation , 2006, The Journal of Immunology.

[47]  I. Azuma,et al.  Mycobacterium bovis BCG Cell Wall-Specific Differentially Expressed Genes Identified by Differential Display and cDNA Subtraction in Human Macrophages , 2004, Infection and Immunity.

[48]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[49]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[50]  L. Lanier,et al.  Inhibition of Immune Responses by ITAM-Bearing Receptors , 2006, Science's STKE.

[51]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[52]  R. Terkeltaub,et al.  Evil humors take their toll as innate immunity makes gouty joints TREM-ble. , 2006, Arthritis and rheumatism.

[53]  S. Akira,et al.  Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis , 2006, Nature Cell Biology.

[54]  S. Giordano,et al.  Semaphorin pathways orchestrate osteogenesis , 2006, Nature Cell Biology.

[55]  L. Lanier,et al.  Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP121 , 2006, The Journal of Immunology.

[56]  C. Confavreux,et al.  Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. , 2005, The American journal of pathology.

[57]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[58]  C. Buonsanti,et al.  Impaired Differentiation of Osteoclasts in TREM-2–deficient Individuals , 2003, The Journal of experimental medicine.

[59]  L. Piccio,et al.  Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.

[60]  P. Maquet,et al.  Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia. , 1997, Journal of medical genetics.

[61]  T. Göbel,et al.  The chicken immunoregulatory receptor families SIRP, TREM, and CMRF35/CD300L , 2006, Immunogenetics.

[62]  L. Lanier,et al.  Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12 , 2005, Nature Immunology.

[63]  I. Wilson,et al.  Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 A. , 2004, Journal of molecular biology.

[64]  S. Hayashi,et al.  Heterogeneity of presenile dementia with bone cysts (Nasu–Hakola disease):: Three genetic forms , 2002, Neurology.

[65]  J. Bartlett,et al.  Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia , 2004 .

[66]  Z. Xing,et al.  Differential Regulation of DAP12 and Molecules Associated with DAP12 during Host Responses to Mycobacterial Infection , 2004, Infection and Immunity.

[67]  R. Spreafico,et al.  Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia , 2004, The European journal of neuroscience.

[68]  T. Tsaganos,et al.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. , 2006, World journal of gastroenterology.

[69]  J. Sutcliffe,et al.  Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.

[70]  M. Gingras,et al.  TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. , 2002, Molecular immunology.

[71]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[72]  P. Sun,et al.  Crystal structure of the human myeloid cell activating receptor TREM-1. , 2003, Structure.

[73]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[74]  J Tanaka,et al.  Nasu–Hakola disease: A review of its leukoencephalopathic and membranolipodystrophic features , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[75]  M. Colonna,et al.  Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. , 2006, Trends in immunology.

[76]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[77]  T. Taniguchi,et al.  Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis , 2004, Nature.

[78]  G. Clark,et al.  The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor. , 1998, International immunology.

[79]  J. Lubkowski,et al.  The Structure of the Extracellular Domain of Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 and Evidence for a Naturally Occurring Soluble Fragment* , 2006, Journal of Biological Chemistry.

[80]  A. Órfão,et al.  Molecular Characterization of a Novel Immune Receptor Restricted to the Monocytic Lineage1 , 2004, The Journal of Immunology.

[81]  L. Peltonen,et al.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.

[82]  H. Kondo,et al.  Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. , 2006, Arthritis and rheumatism.